Insulin Aspart Combo Study Published on Gestational Diabetes Outcomes

A new publication involving insulin aspart appeared on August 15, 2026, in the American Journal of Translational Research. The paper is titled "Insulin plus metformin for gestational diabetes mellitus: impacts on blood glucose, coagulation function, and pregnancy outcomes." It addresses the combined use of insulin and metformin in the context of gestational diabetes mellitus. The publication is listed in PubMed under ID 42769549. This entry represents a new addition to the scientific literature on this topic as of its publication date. No specific findings, results, or outcome data from the study are detailed here. The listing confirms only that the publication exists and identifies its title, journal, and date. Readers interested in the specific methodology, results, or conclusions of this study should consult the original publication directly. For broader context on insulin aspart, including its approved regulatory status and general background, readers can refer to the compound overview.